4//SEC Filing
Kauh John Saewook M.D. 4
Accession 0001415889-25-011114
CIK 0001346830other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:15 PM ET
Size
5.8 KB
Accession
0001415889-25-011114
Insider Transaction Report
Form 4
Kauh John Saewook M.D.
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-04-17+36,210→ 36,210 totalExercise: $17.04Exp: 2035-04-16→ Common Stock (36,210 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on April 17, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Tvardi Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0002064881
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 5:15 PM ET
- Size
- 5.8 KB